Protean Small Cap fell 0.9% in March, outperforming its benchmark's 3.1% decline. Read the full analysis for more details.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results